Aardvark Therapeutics, Inc. (AARD)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
5.65 USD
+5.65
(8.031%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:47 p.m. EDT
High-risk biotech stock with a bloodless pivot: the recent 30%+ crash is driven by a trial pause for cardiac safety issues on ARD-101. While the balance sheet remains solvent ($110M cash), the stock has tanked below its 52-week low, and the forecasting model predicts a further 1.86% decline over the next 45 days with no dividend safety net. The options market has fronted cheap puts at $2.50, signaling fear rather than conviction at current prices. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.782283 |
| AutoETS | 0.782500 |
| MSTL | 0.798787 |
| AutoTheta | 0.927140 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 70.99 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.053 |
| Excess Kurtosis | -1.66 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.414 |
| Market Cap | 123,260,632 |
| Forward P/E | -1.63 |
| Website | https://aardvarktherapeutics.com |
As of April 18, 2026, 11:47 p.m. EDT: Call and Put activity is sparse overall, but puts at the $2.50 strike in August 2026 show significantly higher Open Interest (200) and implied volatility (8.38) compared to calls. This heavy put concentration at a strike ~48% below current price suggests a high strike for 'insurance' against an adverse catalyst or a downside reversion target. ATM and OTM calls show minimal positioning relative to the put data, indicating an asymmetry where downside protection is the primary speculator sentiment.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.26240212 |
| Address1 | 4,370 La Jolla Village Drive |
| Address2 | Suite 1050 |
| All Time High | 19.58 |
| All Time Low | 3.35 |
| Ask | 5.83 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 183,840 |
| Average Daily Volume3 Month | 289,716 |
| Average Volume | 289,716 |
| Average Volume10Days | 183,840 |
| Bid | 5.51 |
| Bid Size | 1 |
| Book Value | 4.888 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.65 |
| Current Ratio | 10.607 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.755 |
| Day Low | 5.16 |
| Debt To Equity | 0.414 |
| Display Name | Aardvark Therapeutics |
| Earnings Timestamp | 1,774,296,000 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -62,689,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.218 |
| Enterprise Value | 13,674,632 |
| Eps Current Year | -3.42111 |
| Eps Forward | -3.4675 |
| Eps Trailing Twelve Months | -2.93 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.0319 |
| Fifty Day Average Change | -1.3818998 |
| Fifty Day Average Change Percent | -0.1965187 |
| Fifty Two Week Change Percent | -26.240211 |
| Fifty Two Week High | 17.94 |
| Fifty Two Week High Change | -12.290001 |
| Fifty Two Week High Change Percent | -0.68506134 |
| Fifty Two Week Low | 3.35 |
| Fifty Two Week Low Change | 2.3000002 |
| Fifty Two Week Low Change Percent | 0.68656725 |
| Fifty Two Week Range | 3.35 - 17.94 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,739,457,000,000 |
| Float Shares | 10,863,516 |
| Forward Eps | -3.4675 |
| Forward P E | -1.629416 |
| Free Cashflow | -31,181,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 40 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16146 |
| Held Percent Institutions | 0.58915 |
| Implied Shares Outstanding | 21,816,041 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-02-13 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California. |
| Long Name | Aardvark Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 123,260,632 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_614979892 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -57,591,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 123,260,631 |
| Number Of Analyst Opinions | 10 |
| Open | 5.16 |
| Operating Cashflow | -54,172,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 858 225 7696 |
| Pre Market Change | -0.07999992 |
| Pre Market Change Percent | -1.4159279 |
| Pre Market Price | 5.57 |
| Pre Market Time | 1,776,758,407 |
| Previous Close | 0.0 |
| Price Eps Current Year | -1.6515108 |
| Price Hint | 2 |
| Price To Book | 1.155892 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.431 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 5.65 |
| Regular Market Change Percent | 8.03059 |
| Regular Market Day High | 5.755 |
| Regular Market Day Low | 5.16 |
| Regular Market Day Range | 5.16 - 5.755 |
| Regular Market Open | 5.16 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 5.65 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 242,369 |
| Return On Assets | -0.40273 |
| Return On Equity | -0.64439005 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 21,816,041 |
| Shares Percent Shares Out | 0.0519 |
| Shares Short | 1,132,986 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,806,347 |
| Short Name | Aardvark Therapeutics, Inc. |
| Short Percent Of Float | 0.078600004 |
| Short Ratio | 2.15 |
| Source Interval | 15 |
| State | CA |
| Symbol | AARD |
| Target High Price | 45.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 16.9 |
| Target Median Price | 14.0 |
| Total Cash | 110,027,000 |
| Total Cash Per Share | 5.043 |
| Total Debt | 441,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | -2.93 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.91775 |
| Two Hundred Day Average Change | -5.2677503 |
| Two Hundred Day Average Change Percent | -0.48249412 |
| Type Disp | Equity |
| Volume | 242,369 |
| Website | https://aardvarktherapeutics.com |
| Zip | 92,122 |